Curated industry list

High-Beta Stocks in Pharmaceuticals on NYSE

Explore High-Beta Stocks in Pharmaceuticals on NYSE. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Bausch Health Companies Inc (BHC)
Fair Value28.4% Upside Undervalued Analyst19.2% Upside Market Cap2.408 B P/E-2.1x Yield0.0% HealthGreat
  NYSE Featured in High-Beta Stocks Small-Cap Stocks
Perrigo Company PLC (PRGO)
Fair Value7.2% Upside Fair Analyst24.3% Upside Market Cap1.495 B P/E-0.8x Yield8.7% HealthFair
  NYSE Featured in High-Beta Stocks Small-Cap Stocks
Nuvation Bio Inc (NUVB)
Fair Value-6.1% Downside Fair Analyst100.6% Upside Market Cap2.242 B P/E-15.2x Yield0.0% HealthFair
  NYSE Featured in High-Beta Stocks
Organon & Co (OGN)
Fair Value29.8% Upside Undervalued Analyst-17.1% Downside Market Cap3.561 B P/E17.1x Yield0.6% HealthFair
  NYSE Featured in High-Beta Stocks
Alto Neuroscience Inc (ANRO)
Fair Value-25.7% Downside Overvalued Analyst27.2% Upside Market Cap1.097 B P/E-14.7x Yield0.0% HealthGood
  NYSE Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks
Explore listed stocks on NYSE with company information and fair value data.